BIOTECH INVESTOR OF THE YEAR, 2000
SI biotech is a collaborative effort among scientists and non-scientists who share a passion for the mixture of big science with sound business strategies. Everyone is welcome, leave the bull at the door.
The best biotech analysis available -- anywhere, at any price -- is found here at SI.
1998 was a tough year for biotech, particularly for small caps. At the end of the year, the strategy of three individuals stood out. Their performance was spectacular -- not above average, but SPECTACULAR. Furthermore, it was documented and archived. I felt compelled to state the obvious, that Vector 1, Peter Suzman and Jim Silverman were 1998's biotech investors of the year.
I didn't plan to make it -- an arrogant pronouncement -- an annual event.
In 1999, however, there was an individual whose performance made the rest of our great 99s look like child's play. His performance was also documented and archived. I therefore opted for arrogance (anyone surprised?); Dr. Miljenko Zuanic was OBVIOUSLY the best of biotech investors for '99.
Now it's tradition.
Year 2000 was a romp. Money washed over the sector, cash looking for a "ride home" from dotcom insanity. New business strategies were born. Quick-witted CFOs held out their arms, facilitating global changes in the nature of biotech-pharma interactions. Biologicals -- largely antibodies -- did a great job of sharing the stage with small molecules.
New business strategies, new companies, new liquidity. But one thing didn't change......
1998
Vector 1, Jim Silverman, Peter Suzman
1999
Miljenko Zuanic
2000
Miljenko Zuanic
Apart from congratulations, no discussion allowed.
:-)
Thanks to all contributors for another year of help and collaboration. Best for the New Year to contributors and lurkers alike!
Rick |
